Inhibition of c-Met as Therapeutic Strategy for Papillary Thyroid Cancer

被引:0
|
作者
Bu, Rong [1 ]
Hussain, Azhar [1 ]
Ahmed, Saeeda [1 ]
Uddin, Shahab [1 ]
Al-Kuraya, Khawla [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4671
引用
收藏
页数:2
相关论文
共 50 条
  • [41] C-Met in Invasive Breast Cancer
    Ho-Yen, Colan M.
    Green, Andrew R.
    Rakha, Emad A.
    Brentnall, Adam R.
    Ellis, Ian O.
    Kermorgant, Stephanie
    Jones, J. L.
    CANCER, 2014, 120 (02) : 163 - 171
  • [42] IGF1R and c-met as therapeutic targets for colorectal cancer
    Shali, Hajar
    Ahmadi, Majid
    Kafil, Hossein Samadi
    Dorosti, Abbasali
    Yousefi, Mehdi
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 82 : 528 - 536
  • [43] SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    Kashiwagi, S.
    Yashiro, M.
    Aomatsu, N.
    Kawajiri, H.
    Takashima, T.
    Onoda, N.
    Ishikawa, T.
    Hirakawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 84 - 84
  • [44] Identification of c-Met as downstream of γ-glutamylcyclotransferase (GGCT), a novel therapeutic target for cancer
    Taniguchi, Keiko
    Saito, Yumiko
    Ii, Hiromi
    Horinaka, Mano
    Kageyama, Susumu
    Nakata, Susumu
    Ukimura, Osamu
    Sakai, Toshiyuki
    CANCER SCIENCE, 2025, 116 : 159 - 159
  • [45] Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma
    Karagonlar, Zeynep F.
    Korhan, Peyda
    Atabey, Nese
    DRUG DEVELOPMENT RESEARCH, 2015, 76 (07) : 357 - 367
  • [46] Diagnosis and therapeutic strategy for papillary thyroid microcarcinoma
    Lin, JD
    Chen, ST
    Chao, TC
    Hsueh, C
    Weng, HF
    ARCHIVES OF SURGERY, 2005, 140 (10) : 940 - 945
  • [47] Functional expression of c-Met and its therapeutic inhibition with SU11274 and siRNA in nonsmall cell lung cancer
    Ma, PC
    Jagadeeswaran, R
    Jagadeesh, S
    Tretiakova, MS
    Nallasura, V
    Uppalapati, R
    Husain, AN
    Christensen, JG
    Salgia, R
    LUNG CANCER, 2004, 46 : S49 - S49
  • [48] Attacking EGFR mutant lung cancer by combined EGFR and c-Met inhibition
    Ortiz-Cuaran, Sandra
    Schoettle, Jakob
    Dahmen, Ilona
    Peifer, Martin
    Wieczoreck, Caroline
    Koker, Mirjam
    Ihle, Michaela A.
    Florin, Alexandra
    Pinther, Berit
    Heukamp, Lukas C.
    Ullrich, Roland T.
    Thomas, Roman K.
    CANCER RESEARCH, 2014, 74 (19)
  • [49] VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
    You, Weon-Kyoo
    Sennino, Barbara
    Williamson, Casey W.
    Falcon, Beverly
    Hashizume, Hiroya
    Yao, Li-Chin
    Aftab, Dana T.
    McDonald, Donald M.
    CANCER RESEARCH, 2011, 71 (14) : 4758 - 4768
  • [50] Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer
    Theodore F. Logan
    Current Oncology Reports, 2013, 15 : 83 - 90